We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AT&T
T
$166B
| $53.8M | 0.21% |
2,446,135
+131,625
| +6% | +$2.62M |
|
|
CYBR
102
DELISTED
CyberArk
CYBR
| $52.5M | 0.21% |
179,960
+8,879
| +5% | +$2.4M |
|
103
Medtronic
MDT
$116B
| $51.2M | 0.2% |
568,985
+20,701
| +4% | +$1.74M |
|
104
Progressive
PGR
$121B
| $50.9M | 0.2% |
200,611
+16,188
| +9% | +$3.76M |
|
105
Automatic Data Processing
ADP
$107B
| $50.3M | 0.2% |
181,874
+11,231
| +7% | +$2.94M |
|
106
Analog Devices
ADI
$187B
| $49.9M | 0.2% |
216,935
+2,081
| +1% | +$469K |
|
107
Applied Industrial Technologies
AIT
$13B
| $49.5M | 0.2% |
221,823
+49,500
| +29% | +$10.1M |
|
108
Pinduoduo
PDD
$127B
| $48.8M | 0.19% |
362,319
-9,211
| -2% | -$1.13M |
|
109
Lowe's Companies
LOW
$121B
| $47.2M | 0.19% |
174,318
+2,199
| +1% | +$533K |
|
110
American Tower
AMT
$79.4B
| $46.7M | 0.18% |
200,713
+3,418
| +2% | +$758K |
|
111
Nike
NKE
$60.1B
| $46.3M | 0.18% |
524,145
+12,020
| +2% | +$943K |
|
112
Morgan Stanley
MS
$342B
| $45.9M | 0.18% |
440,023
+584
| +0.1% | +$58.8K |
|
113
KLA
KLAC
$272B
| $45.7M | 0.18% |
590,280
+15,510
| +3% | +$1.22M |
|
114
Mercado Libre
MELI
$92.7B
| $45.5M | 0.18% |
22,191
+457
| +2% | +$860K |
|
115
Lam Research
LRCX
$408B
| $45.5M | 0.18% |
557,760
+7,650
| +1% | +$665K |
|
116
Gilead Sciences
GILD
$168B
| $45.2M | 0.18% |
538,703
-10,722
| -2% | -$818K |
|
117
Micron Technology
MU
$1.03T
| $45.1M | 0.18% |
434,596
+9,992
| +2% | +$1.04M |
|
118
Blackrock
BLK
$180B
| $44.8M | 0.18% |
47,217
+390
| +0.8% | +$338K |
|
119
Prologis
PLD
$134B
| $44.8M | 0.18% |
354,686
+8,380
| +2% | +$1.04M |
|
120
Darling Ingredients
DAR
$10B
| $44.7M | 0.18% |
1,204,023
+6,200
| +0.5% | +$234K |
|
121
First Solar
FSLR
$24.4B
| $44.5M | 0.18% |
178,266
+95,167
| +115% | +$21.4M |
|
122
NetEase
NTES
$79.5B
| $43.7M | 0.17% |
467,220
-56,000
| -11% | -$4.89M |
|
123
Motorola Solutions
MSI
$77.7B
| $43.4M | 0.17% |
96,422
+9,936
| +11% | +$4.14M |
|
124
Brown & Brown
BRO
$23.8B
| $43M | 0.17% |
415,134
+367,500
| +772% | +$36.5M |
|
125
Universal Display
OLED
$4.23B
| $42.8M | 0.17% |
204,120
-15,607
| -7% | -$3.16M |
|
Similar funds
VIA
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.